{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:00:20Z","timestamp":1789729220626,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.autrev.2023.103297","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T11:13:25Z","timestamp":1676114005000},"page":"103297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"Omer Nuri","family":"Pamuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saja Mustafa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfaraz","family":"Hasni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2023.103297_bb0005","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/j.seminhematol.2016.04.005","article-title":"T cells in the pathogenesis of immune thrombocytopenia","volume":"53","author":"Wei","year":"2016","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.autrev.2023.103297_bb0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2023.103297_bb0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/annrheumdis-2020-217356","article-title":"Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or \u2018blood-dominant\u2019 lupus?","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2023.103297_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2018.38","article-title":"The non-haemostatic role of platelets in systemic lupus erythematosus","volume":"14","author":"Linge","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.autrev.2023.103297_bb0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/annrheumdis-2020-217013","article-title":"Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study","volume":"79","author":"Zhu","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2023.103297_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/09537101003735564","article-title":"Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis","volume":"21","author":"Zhao","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.autrev.2023.103297_bb0035","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/ard.2004.033100","article-title":"Lupus thrombocytopenia: clinical implications and prognostic significance","volume":"64","author":"Ziakas","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2023.103297_bb0040","first-page":"1","article-title":"Correspondance on \u2018risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anemia: a nationwide French study\u2019","volume":"0","author":"Maquet","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2023.103297_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000523","article-title":"ANA-positive primary immune thrombocytopenia: a different clinical entity with increased risk of connective tissue diseases","volume":"8","author":"Liu","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.autrev.2023.103297_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Br. Med. J."},{"key":"10.1016\/j.autrev.2023.103297_bb0055","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2023.103297_bb0060","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/0003-4819-103-4-548","article-title":"Fluorescent antinuclear antibodies and anti-SS-A\/Ro in patients with immune thrombocytopenia subsequently developing systemic lupus erythematosus","volume":"103","author":"Anderson","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.autrev.2023.103297_bb0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/art.1780280527","article-title":"Idiopathic thrombocytopenic purpura with high-titer, speckled pattern antinuclear antibodies: possible marker for systemic lupus erythematosus","volume":"28","author":"Perez","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2023.103297_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.2830320205","article-title":"Antinuclear antibodies in patients with chronic idiopathic autoimmune thrombocytopenia followed 2-30 years","volume":"32","author":"Panzer","year":"1989","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.autrev.2023.103297_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2169\/internalmedicine1962.29.481","article-title":"Thrombocytopenia subsequently develops systemic lupus erythematosus \u2013can anti-SS-A antibody predict the next event?","volume":"29","author":"Adachi","year":"1990","journal-title":"Jpn. J. Med."},{"key":"10.1016\/j.autrev.2023.103297_bb0080","first-page":"184","article-title":"High-titer antinuclear antibodies, anti-SSA\/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura","volume":"71","author":"Kurata","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.autrev.2023.103297_bb0085","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1182\/blood.V84.12.4203.bloodjournal84124203","article-title":"Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura","volume":"84","author":"Stasi","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103297_bb0090","first-page":"867","article-title":"Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus","volume":"24","author":"Mestanza-Peralta","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2023.103297_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00043426-199707000-00006","article-title":"Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura","volume":"19","author":"Zimmerman","year":"1997","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.autrev.2023.103297_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0037-1613754","article-title":"Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset","volume":"83","author":"Vantelon","year":"2000","journal-title":"Thromb. Haemast."},{"key":"10.1016\/j.autrev.2023.103297_bb0105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s002770100306","article-title":"Clinicopathologic and prognostic features of chronic idiopathic thrombocytopenic purpura in adult Chinese patients: ANA analysis of 220 cases","volume":"80","author":"Leung","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.autrev.2023.103297_bb0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00277-002-0488-x","article-title":"Overview of 321 patients with idiopathic thrombocytopenic purpura: retrospective analysis of the clinical features and response to therapy","volume":"81","author":"Pamuk","year":"2002","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.autrev.2023.103297_bb0115","first-page":"36","article-title":"Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases","volume":"118","author":"Li","year":"2005","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.autrev.2023.103297_bb0120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/pbc.20970","article-title":"Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura","volume":"47","author":"Hazzan","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.autrev.2023.103297_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11239-007-0031-y","article-title":"Prevalence and clinical significance of elavted antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura","volume":"24","author":"Altintas","year":"2007","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.autrev.2023.103297_bb0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00277-008-0448-1","article-title":"A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura","volume":"87","author":"Abbasi","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.autrev.2023.103297_bb0135","first-page":"742","article-title":"The antiphospholipid antibodies, a risk factor to developed antiphospholipide syndrome or systemic lupus erythematous in the patients with immune thrombocytopenic purpura (ITP)","volume":"98","author":"Gaman","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2023.103297_bb0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00277-014-2220-z","article-title":"Immune thrombocytopenia: epidemiological and clinical features of 216 patients in northwestern Turkey","volume":"94","author":"Koylu","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.autrev.2023.103297_bb0145","first-page":"840","article-title":"Risk of lupus after primary immune thrombocytopenic purpura: a 14 year single center experience","volume":"102","author":"Ayesh","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2023.103297_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.24702","article-title":"Newly diagnosed immune thrombocytopenia adults: clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort","volume":"92","author":"Moulis","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.autrev.2023.103297_bb0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/apa.15593","article-title":"Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in childhood immune thrombocytopenia","volume":"110","author":"Saettini","year":"2021","journal-title":"Acta Pediatrica."},{"key":"10.1016\/j.autrev.2023.103297_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29146","article-title":"Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: prevalence and risk factors","volume":"68","author":"Kittivisuit","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.autrev.2023.103297_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-022-02901-y","article-title":"Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia","volume":"24","author":"Ahn","year":"2022","journal-title":"Arthritis. Res. Ther."},{"issue":"Suppl","key":"10.1016\/j.autrev.2023.103297_bb0170","first-page":"2872","article-title":"Immune thrombocytopenic purpura and subsequent development of systemic lupus erythematosus","volume":"74","author":"Alle","year":"2022","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2023.103297_bb0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat. Immun."},{"key":"10.1016\/j.autrev.2023.103297_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110171","article-title":"The impact of sex on susceptibility to systemic lupus erythematosus and rheumatoid arthritis; a bioinformatics point of view","volume":"88","author":"Ramezankhani","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.autrev.2023.103297_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/ATVBAHA.116.308126","article-title":"Activated platelets induce endothelial cell activation via an interleukin-1B pathway in systemic lupus erythematosus","volume":"37","author":"Nhek","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.autrev.2023.103297_bb0190","doi-asserted-by":"crossref","first-page":"102887","DOI":"10.1016\/j.jaut.2022.102887","article-title":"Systemic lupus erythematosus-complicating immune thrombocytopenia: from pathogenesis to treatment","author":"Jiang","year":"2022","journal-title":"J. Autoimmun."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:25Z","timestamp":1761600445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1568997223000319"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103297","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103297"}}